Abstract
(i) Evaluate the predictive performance of the fractal volume of drug distribution, v(f), (Pharm. Res.18, 1056, 2001), (ii) develop the concept of the fractal clearance, CLf, which is the clearance analogue of v(f), (iii) examine the utility of CLf in allometric studies, (iv) develop allometric relationships for the elimination half-life, t1/2, and (v) evaluate the use of v(f) and CLf in predicting the volume of drug distribution, Vap, clearance, CL, and elimination half-life, t1/2. Estimates for v(f) of various drugs were obtained and correlated with body mass using data only from animal species. A comparison was made between the predicted and actual v(f) values for humans. For a variety of animal species CLf values were estimated from the equation: [equation: see text]. The allometric equations developed using CLf were compared with other allometric approaches. Allometric equations were also developed for t1/2 utilizing the allometric relationships of v(f) and CLf, The predicted estimates of v(f) were very close to the actual values and the correlation exhibited favorable statistical properties. The values of the allometric exponents for CLf were found to be close to 0.75. The predictive performance for CL using the allometric equations for CLf in conjunction with the rule of exponents was found to be better than the currently considered most accurate allometric approaches. The values of the allometric exponents for t1/2 were found to be close to 0.25 The predictive ability of v(f) is high; predictions for Vap based on v(f) values are better than the current approaches. CLf expressed a good behavior both in prospective and retrospective analysis. The allometric exponents, 0.75, 0.25 for CLf and t1/2, respectively, agree with the theoretical expected values.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.